![Thomas L. Gutshall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas L. Gutshall
Directeur/Membre du Conseil chez
Pacific Medical Research Foundation
Profil
Thomas L.
Gutshall is the founder of CEPHEID, which was founded in 1996.
He served as Chairman from 2002 to 2013.
Currently, he holds director positions at Profusa, Inc., Pacific Medical Research Foundation, Silver Bullet Therapeutics, Inc., and is an advisor at 1Flourish Capital LLC.
Previously, he served as a Director at CV Therapeutics, Inc. from 1994 to 2009, and as a Director at Metrika, Inc. and Satoris, Inc. He also served as Executive Vice President at Syntex Corp.
from 1989 to 1994.
Mr. Gutshall received his undergraduate degree from the University of Delaware in 1960.
Postes actifs de Thomas L. Gutshall
| Sociétés | Poste | Début |
|---|---|---|
Pacific Medical Research Foundation | Directeur/Membre du Conseil | - |
Profusa, Inc. (California)
 Profusa, Inc. (California) Electronic Equipment/InstrumentsElectronic Technology Manufactures tissue integrated biosensors for continuous monitoring of body chemistries | Directeur/Membre du Conseil | 01/01/2012 |
Silver Bullet Therapeutics, Inc.
 Silver Bullet Therapeutics, Inc. BiotechnologyHealth Technology Develops antimicrobial coating based on proprietary silver ionization technology for medical devices | Directeur/Membre du Conseil | - |
1Flourish Capital LLC
 1Flourish Capital LLC Investment ManagersFinance 1Flourish Capital invests in companies located in the United States. The firm targets companies operating in the field of the deep technology such as physical AI, defense technology and dual-use innovation sector. It provides financing for pre-seed, seed and early-stage capital requirements. | Consultant / Advisor | - |
Anciens postes connus de Thomas L. Gutshall
| Sociétés | Poste | Fin |
|---|---|---|
Satoris, Inc.
 Satoris, Inc. Miscellaneous Commercial ServicesCommercial Services Develops tests for neurological diseases | Directeur/Membre du Conseil | 01/01/2011 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Directeur/Membre du Conseil | 17/04/2009 |
Syntex Corp.
 Syntex Corp. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Corporate Officer/Principal | 01/12/1994 |
Metrika, Inc.
 Metrika, Inc. BiotechnologyHealth Technology Manufactures and markets diabetes monitoring products | Directeur/Membre du Conseil | - |
| CEPHEID | Directeur Général | 22/04/2002 |
Formation de Thomas L. Gutshall
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Syntex Corp.
Syntex Corp. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Health Technology |
CEPHEID
 CEPHEID Medical SpecialtiesHealth Technology Develops, manufactures and markets molecular diagnostic systems | Health Technology |
Metrika, Inc.
Metrika, Inc. BiotechnologyHealth Technology Manufactures and markets diabetes monitoring products | Health Technology |
Satoris, Inc.
Satoris, Inc. Miscellaneous Commercial ServicesCommercial Services Develops tests for neurological diseases | Commercial Services |
Profusa, Inc. (California)
Profusa, Inc. (California) Electronic Equipment/InstrumentsElectronic Technology Manufactures tissue integrated biosensors for continuous monitoring of body chemistries | Electronic Technology |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pacific Medical Research Foundation | |
Silver Bullet Therapeutics, Inc.
Silver Bullet Therapeutics, Inc. BiotechnologyHealth Technology Develops antimicrobial coating based on proprietary silver ionization technology for medical devices | Health Technology |
1Flourish Capital LLC
1Flourish Capital LLC Investment ManagersFinance 1Flourish Capital invests in companies located in the United States. The firm targets companies operating in the field of the deep technology such as physical AI, defense technology and dual-use innovation sector. It provides financing for pre-seed, seed and early-stage capital requirements. | Finance |
